Viewing Study NCT02480712


Ignite Creation Date: 2025-12-26 @ 10:20 PM
Ignite Modification Date: 2025-12-26 @ 10:20 PM
Study NCT ID: NCT02480712
Status: COMPLETED
Last Update Posted: 2018-11-16
First Post: 2015-06-22
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection
Sponsor: Gilead Sciences
Organization: